Stock Analysis on Net
Stock Analysis on Net

Altria Group Inc. (NYSE:MO)

This company has been moved to the archive! The financial data has not been updated since October 31, 2024.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Altria Group Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Short-term borrowings 0.00 0.00 0.00 0.00 0.00 5.38 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.70 0.00 0.00 0.00 0.00
Current portion of long-term debt 4.64 4.52 0.00 2.91 3.07 3.02 3.64 4.21 4.25 7.17 6.26 2.80 2.79 0.00 3.08 3.16 3.22 2.99 0.00 2.03 1.89 3.73 3.62
Accounts payable 1.49 1.62 1.38 1.51 1.34 1.22 1.12 1.49 1.23 1.08 0.94 1.14 0.67 0.59 0.56 0.80 0.75 0.54 0.53 0.66 0.46 0.39 0.35
Marketing 2.39 2.22 1.97 1.86 1.82 1.86 1.59 1.62 2.04 1.93 1.64 1.68 1.72 1.54 1.12 1.10 1.12 0.97 0.89 0.80 1.05 1.00 0.83
Settlement charges 6.20 3.84 9.38 6.65 6.55 4.20 10.37 7.92 8.04 4.76 10.51 8.47 7.57 4.46 9.31 7.52 6.87 4.13 8.40 6.79 5.85 3.51 7.37
Other 3.59 5.53 5.21 4.93 3.50 3.93 3.54 3.52 3.30 3.25 3.75 3.45 2.80 2.85 3.18 3.15 2.39 6.98 2.71 3.14 2.26 2.59 2.38
Accrued liabilities 12.18% 11.58% 16.56% 13.43% 11.87% 9.99% 15.51% 13.05% 13.38% 9.94% 15.89% 13.61% 12.09% 8.85% 13.60% 11.77% 10.37% 12.08% 11.99% 10.72% 9.15% 7.11% 10.58%
Deferred gain from the sale of IQOS System commercialization rights 0.00 0.00 7.40 7.00 7.40 7.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividends payable 5.09 4.91 4.63 4.50 4.78 4.51 4.58 4.56 4.99 4.44 4.07 4.17 4.20 3.59 3.28 3.38 3.43 3.12 2.97 3.18 2.97 2.61 2.53
Liabilities held for sale 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current liabilities 23.40% 22.63% 29.98% 29.35% 28.47% 31.40% 24.84% 23.32% 23.85% 22.62% 27.16% 21.71% 20.50% 13.03% 20.51% 19.11% 17.77% 18.73% 21.20% 16.59% 14.48% 13.83% 17.08%
Long-term debt, excluding current portion 68.98 68.25 68.66 65.11 65.75 64.80 65.30 67.99 73.18 68.16 63.14 68.16 68.30 63.62 57.77 58.99 59.49 54.86 51.26 54.88 50.84 47.12 45.62
Deferred income taxes 9.39 9.54 7.40 7.26 6.93 7.12 7.43 7.84 9.81 10.61 9.36 9.34 8.99 10.77 9.69 9.56 10.13 9.66 9.87 10.32 9.90 9.35 9.04
Accrued pension costs 0.37 0.37 0.35 0.34 0.35 0.34 0.35 0.36 0.58 0.54 0.49 0.51 0.71 0.93 0.99 1.16 0.87 0.75 0.81 0.96 0.67 0.76 0.84
Accrued postretirement health care costs 3.19 3.16 2.96 2.80 3.01 2.94 2.95 2.93 4.23 3.91 3.57 3.63 3.82 3.41 4.00 4.11 3.85 3.59 3.42 3.65 3.33 3.07 2.98
Deferred gain from the sale of IQOS System commercialization rights 0.00 0.00 0.00 0.00 0.00 0.00 7.33 7.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other liabilities 4.67 4.67 4.54 4.20 4.71 3.56 2.20 0.88 0.82 0.71 0.64 0.72 0.78 0.80 0.81 0.80 0.88 0.82 0.76 0.70 0.60 0.63 0.60
Non-current liabilities 86.60% 85.99% 83.90% 79.70% 80.74% 78.77% 85.55% 87.30% 88.62% 83.92% 77.21% 82.36% 82.60% 79.54% 73.27% 74.63% 75.22% 69.67% 66.12% 70.51% 65.34% 60.95% 59.08%
Total liabilities 110.00% 108.63% 113.88% 109.05% 109.21% 110.17% 110.39% 110.62% 112.46% 106.54% 104.37% 104.06% 103.10% 92.57% 93.78% 93.75% 92.99% 88.40% 87.31% 87.10% 79.82% 74.78% 76.16%
Redeemable noncontrolling interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.09 0.08 0.08 0.08 0.08 0.07 0.08 0.07 0.07 0.06
Common stock, par value $0.33 1/3 per share 2.74 2.72 2.56 2.42 2.56 2.52 2.54 2.53 2.75 2.54 2.32 2.37 2.36 2.11 1.92 1.97 2.00 1.86 1.78 1.90 1.77 1.63 1.58
Additional paid-in capital 17.24 17.09 15.14 15.31 16.16 15.83 15.93 15.93 17.30 15.95 14.53 14.82 14.78 13.16 12.11 12.46 12.80 11.88 11.33 12.12 11.26 10.35 10.03
Earnings reinvested in the business 100.11 97.86 86.46 80.62 84.36 81.67 81.19 80.62 84.78 82.33 77.02 77.59 77.56 79.00 70.75 73.14 73.64 73.52 69.42 74.16 75.43 76.66 73.58
Accumulated other comprehensive losses -7.66 -6.64 -6.21 -6.93 -6.78 -7.29 -7.55 -7.50 -7.02 -6.47 -7.36 -7.73 -8.67 -8.11 -7.74 -9.16 -8.10 -7.52 -4.81 -5.81 -4.54 -4.60 -4.59
Cost of repurchased stock -122.58 -119.80 -111.96 -100.60 -105.66 -103.02 -102.63 -102.33 -110.28 -100.89 -90.89 -91.10 -89.23 -78.81 -71.06 -72.43 -73.62 -68.42 -65.27 -69.73 -63.99 -58.88 -56.83
Stockholders’ equity (deficit) attributable to Altria -10.15% -8.77% -14.02% -9.18% -9.34% -10.30% -10.53% -10.75% -12.46% -6.54% -4.37% -4.06% -3.20% 7.34% 5.97% 5.99% 6.73% 11.33% 12.43% 12.63% 19.93% 25.15% 23.77%
Noncontrolling interests 0.15 0.15 0.14 0.13 0.14 0.13 0.14 0.14 0.00 0.00 0.00 0.00 0.01 0.00 0.17 0.18 0.20 0.20 0.18 0.20 0.17 0.00 0.00
Total stockholders’ equity (deficit) -10.00% -8.63% -13.88% -9.05% -9.21% -10.17% -10.39% -10.62% -12.46% -6.54% -4.37% -4.06% -3.20% 7.34% 6.14% 6.17% 6.93% 11.53% 12.61% 12.82% 20.10% 25.16% 23.77%
Total liabilities and stockholders’ equity (deficit) 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

A comprehensive analysis of the balance sheet structure reveals a significant shift in the capital composition, characterized by a transition from a positive equity position to a stockholders' deficit and a corresponding increase in total liabilities. Total liabilities have expanded from 76.16% of total liabilities and stockholders' equity in March 2019 to 110.00% by September 2024, indicating a heightened reliance on debt and other obligations to fund operations and capital activities.

Long-Term Debt and Non-Current Liabilities
A persistent upward trend is observed in non-current liabilities, which rose from 59.08% in early 2019 to 86.60% by September 2024. This growth is primarily driven by long-term debt (excluding the current portion), which increased from 45.62% to 68.98% over the period. The expansion of long-term leverage suggests a strategic decision to utilize debt markets for long-term financing.
Current Liabilities and Short-Term Obligations
Current liabilities exhibited general growth, moving from 17.08% in March 2019 to 23.40% in September 2024, with a peak of 31.40% in June 2023. Within this category, settlement charges demonstrate significant volatility, fluctuating between approximately 3.5% and 10.5%, reflecting the episodic nature of these obligations. Dividends payable have also trended upward, increasing from 2.53% to 5.09%, indicating a growing proportion of the balance sheet dedicated to shareholder distributions.
Stockholders' Equity and Capital Management
The most notable trend is the decline of total stockholders' equity from a positive 23.77% in March 2019 to a deficit of -10.00% by September 2024. The transition into a deficit position occurred in the third quarter of 2021. This deficit is not the result of operating losses, as earnings reinvested in the business grew from 73.58% to 100.11% over the same period. Instead, the deficit is driven by an aggressive share repurchase program, as the cost of repurchased stock expanded from -56.83% in March 2019 to -122.58% in September 2024.
Other Balance Sheet Components
Deferred income taxes remained relatively stable, fluctuating between 6.93% and 10.77%. Additionally, the introduction of deferred gains from the sale of IQOS System commercialization rights appeared as a liability component starting in late 2022 and 2023, contributing approximately 7% to the total liabilities and stockholders' equity during those specific intervals.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?